Morgan Stanley Knock-Out SSNHZ/ DE000MD9SED9 /
05/07/2024 14:36:05 | Chg.+0.58 | Bid22:00:33 | Ask22:00:33 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.71EUR | +14.04% | - Bid Size: - |
- Ask Size: - |
Samsung Electronics ... | 1,077.0491 - | 31/12/2078 | Call |
GlobeNewswire
01/07
FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar to Stelara
GlobeNewswire
26/06
Primarius NanoSpice™ Simulator Certified for Samsung Foundry 3nm/4nm Process Technology
GlobeNewswire
25/06
Pixalate Releases Top 100 Connected TV (CTV) Bundle ID Rankings For Global Open Programmatic Ad Spen...
GlobeNewswire
25/06
Samsung Bioepis Releases 2024 Sustainability Report, Highlighting Progress in Accessibility and R&D ...
GlobeNewswire
14/06
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
15/05
Pixalate’s April 2024 Top Grossing Connected TV (CTV) Apps Based on Global Open Programmatic Ad Reve...
GlobeNewswire
09/05
Pixalate Releases Top 100 Connected TV (CTV) Bundle ID Rankings For Global Open Programmatic Adverti...
GlobeNewswire
02/05
Pixalate Releases LATAM Q1 2024 Connected TV (CTV) Device Market Share Report: Roku Leads with 39% M...
GlobeNewswire
02/05
Wearable Devices Invited to Present its Gesture Control Technology to Samsung's Senior Management in...
GlobeNewswire
26/04
Pixalate’s Q1 2024 Top Grossing Samsung Smart TV Connected TV (CTV) Apps Based on Global Open Progra...